retatrutide
| SMILES | CC[C@H](C)C(C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N[C@@H](CO)C(=O)N)NC(=O)[C@H](CC6=CC=CC=C6)NC(=O)[C@H](C)NC(=O)C(C)(C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)CC[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(CC(C)C)NC(=O)C([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CC=C(C=C7)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC8=CC=CC=C8)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)C(C)(C)NC(=O)[C@H](CC9=CC=C(C=C9)O)N |
| InChIKey | MLOLQJNKXBNWFW-SAGGEDDASA-N |
Chemical properties
| Hydrogen bond acceptors | 64 |
| Hydrogen bond donors | 58 |
| Rotatable bonds | 159 |
| Molecular weight (Da) | 4728.5 |
Drug properties
| Molecular type | Protein |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| GIP | GIPR | Human | Glucagon | B1 | pKi | 10.24 | 10.24 | 10.24 | Guide to Pharmacology |
| GLP-1 | GLP1R | Human | Glucagon | B1 | pKi | 8.14 | 8.14 | 8.14 | Guide to Pharmacology |
| glucagon | GLR | Human | Glucagon | B1 | pKi | 8.25 | 8.25 | 8.25 | Guide to Pharmacology |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| GIP | GIPR | Human | Glucagon | B1 | pEC50 | 10.19 | 10.19 | 10.19 | Guide to Pharmacology |
| GLP-1 | GLP1R | Human | Glucagon | B1 | pEC50 | 9.11 | 9.11 | 9.11 | Guide to Pharmacology |
| glucagon | GLR | Human | Glucagon | B1 | pEC50 | 8.24 | 8.24 | 8.24 | Guide to Pharmacology |